{"id":"duratocin","rwe":[],"tags":[],"phase":"phase_1","safety":{"boxedWarnings":[],"safetySignals":[],"drugInteractions":[],"commonSideEffects":[],"contraindications":[],"specialPopulations":{},"discontinuationRates":[],"seriousAdverseEvents":[]},"status":"active","trials":["NCT06946589","NCT03168698","NCT03408054","NCT06285409","NCT03672045","NCT03959436","NCT02264769","NCT01719952","NCT04902729","NCT02636816","NCT01262742","NCT01428817","NCT06333340","NCT04182360","NCT01651130","NCT02079558","NCT02861482","NCT01725243","NCT01689298","NCT01579201","NCT03404544"],"aliases":[],"patents":[],"pricing":[],"offLabel":[],"timeline":[],"aiSummary":"","brandName":"Duratocin","companyId":"dongyu-wang","ecosystem":[],"mechanism":{"target":"Oxytocin receptor, Vasopressin V1a receptor, Vasopressin V2 receptor","novelty":"","modality":"Small molecule","drugClass":"","explanation":"","oneSentence":"","technicalDetail":""},"commercial":null,"references":[],"biosimilars":[],"companyName":"Dongyu Wang","competitors":[],"dataSources":[{"url":"https://clinicaltrials.gov","name":"ClinicalTrials.gov","fields":["trialDetails","trials"],"retrievedDate":"2026-04-07"},{"url":"https://drugcentral.org","name":"DrugCentral","fields":["indications","contraindications","safety","target","drugInteractions"],"retrievedDate":"2026-04-07"}],"genericName":"Duratocin","indications":{"approved":[{"name":"Atony of uterus","diseaseId":"atony-of-uterus","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Prader-Willi syndrome","diseaseId":"prader-willi-syndrome","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"}],"offLabel":[],"pipeline":[]},"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT06946589","phase":"Phase 4","title":"Cardiac Changes After Effective Dose Carbetocin for Elective Caesarian Section","status":"NOT_YET_RECRUITING","sponsor":"Jordan Leitch","isPivotal":false,"enrollment":200,"indication":"Cardiac Ischemia, Cesarian Section","completionDate":"2027-09-01"},{"nctId":"NCT03168698","phase":"NA","title":"Carbetocin vs. Oxytocin at Elective Cesarean Section: a Double-blind, Randomized Controlled Non-inferiority Trial of High and Low Dose Regimens","status":"COMPLETED","sponsor":"Samuel Lunenfeld Research Institute, Mount Sinai Hospital","isPivotal":false,"enrollment":278,"indication":"Postpartum Hemorrhage","completionDate":"2020-12-18"},{"nctId":"NCT03408054","phase":"NA","title":"The Relaxant Effect of Nitroglycerin on Oxytocin Desensitized Human Myometrium and the Return of Contractility on Re-exposure to Oxytocin- an in Vitro Study","status":"COMPLETED","sponsor":"Samuel Lunenfeld Research Institute, Mount Sinai Hospital","isPivotal":false,"enrollment":17,"indication":"Postpartum Hemorrhage","completionDate":"2018-04-13"},{"nctId":"NCT06285409","phase":"NA","title":"Comparing the Dose-response Profiles of Uterotonics After Initial Carbetocin Administration - an Ex-vivo Study in Desensitized Human Myometrium","status":"RECRUITING","sponsor":"Samuel Lunenfeld Research Institute, Mount Sinai Hospital","isPivotal":false,"enrollment":32,"indication":"Postpartum Hemorrhage","completionDate":"2026-12"},{"nctId":"NCT03672045","phase":"NA","title":"Carbetocin at Elective Cesarean Deliveries: A Dose-finding Study in Women With BMI ≥ 40kg/m2","status":"COMPLETED","sponsor":"Samuel Lunenfeld Research Institute, Mount Sinai Hospital","isPivotal":false,"enrollment":30,"indication":"Postpartum Hemorrhage","completionDate":"2019-05-17"},{"nctId":"NCT03959436","phase":"N/A","title":"Prospective Observational Database Evaluating Outcomes of Using Carbetocin (Duratocin®) as the Primary Uterotonic Following Cesarean Delivery at Maisonneuve-Rosemont Hospital","status":"COMPLETED","sponsor":"Maisonneuve-Rosemont Hospital","isPivotal":false,"enrollment":612,"indication":"Carbetocin, Cesarean Section Complications","completionDate":"2018-03-16"},{"nctId":"NCT02264769","phase":"NA","title":"Carbetocin at Elective Cesarean Deliveries: A Non-inferiority Study Between 20 and 100 Micrograms - Part 4","status":"COMPLETED","sponsor":"Samuel Lunenfeld Research Institute, Mount Sinai Hospital","isPivotal":false,"enrollment":110,"indication":"Postpartum Hemorrhage","completionDate":"2015-05"},{"nctId":"NCT01719952","phase":"NA","title":"Comparison of Haemodynamic and Cardiovascular Effects of Carbetocin and Oxytocin in Women Undergoing Elective Caesarean Section: A Double-blinded Randomised Clinical Trial","status":"COMPLETED","sponsor":"Universiti Kebangsaan Malaysia Medical Centre","isPivotal":false,"enrollment":50,"indication":"Pregnancy Related, Anaesthesia","completionDate":"2014-01"},{"nctId":"NCT04902729","phase":"NA","title":"Oxytocin Vs Carbetocin at Cesarean Delivery in Women With Morbid Obesity: Double-blind, Randomised Control, Non-inferiority Trial","status":"COMPLETED","sponsor":"Samuel Lunenfeld Research Institute, Mount Sinai Hospital","isPivotal":false,"enrollment":48,"indication":"Post Partum Hemorrhage","completionDate":"2022-12-09"},{"nctId":"NCT02636816","phase":"Phase 4","title":"Cardiovascular Effects of Carbetocin During Elective Caesarean Delivery: A Randomized Controlled Trial Comparing Infusion Versus Bolus Administration Using Nexfin™","status":"COMPLETED","sponsor":"University of British Columbia","isPivotal":false,"enrollment":57,"indication":"Effect of Carbetocin on Cardiovascular System, Pregnancy","completionDate":"2016-06"},{"nctId":"NCT01262742","phase":"NA","title":"Carbetocin at Elective Cesarean Delivery: A Dose Finding Study","status":"COMPLETED","sponsor":"Samuel Lunenfeld Research Institute, Mount Sinai Hospital","isPivotal":false,"enrollment":80,"indication":"Postpartum Hemorrhage","completionDate":"2011-03"},{"nctId":"NCT01428817","phase":"NA","title":"Carbetocin at Elective Cesarean Delivery: A Dose Finding Study (Part 2)","status":"COMPLETED","sponsor":"Samuel Lunenfeld Research Institute, Mount Sinai Hospital","isPivotal":false,"enrollment":120,"indication":"Postpartum Hemorrhage","completionDate":"2011-12"},{"nctId":"NCT06333340","phase":"NA","title":"Comparative Efficacy of Carbetocin and Oxytocin in Parturients at Risk of Atonic Postpartum Hemorrhage Undergoing Elective Cesarean Delivery: a Randomized Controlled Trial","status":"RECRUITING","sponsor":"Samuel Lunenfeld Research Institute, Mount Sinai Hospital","isPivotal":false,"enrollment":160,"indication":"Post Partum Hemorrhage","completionDate":"2026-12"},{"nctId":"NCT04182360","phase":"NA","title":"Carbetocin at Elective Cesarean Deliveries: A Dose-finding Study in Women With Twin Pregnancy.","status":"COMPLETED","sponsor":"Samuel Lunenfeld Research Institute, Mount Sinai Hospital","isPivotal":false,"enrollment":30,"indication":"Postpartum Hemorrhage, Twin","completionDate":"2023-04-28"},{"nctId":"NCT01651130","phase":"NA","title":"Carbetocin at Elective Cesarean Deliveries: A Dose-finding Study Part 3","status":"COMPLETED","sponsor":"Samuel Lunenfeld Research Institute, Mount Sinai Hospital","isPivotal":false,"enrollment":40,"indication":"Postpartum Hemorrhage","completionDate":"2012-08"},{"nctId":"NCT02079558","phase":"Phase 2","title":"Efficacy of Oxytocin vs. Carbetocin in Prevention of Postpartum Hemorrhage After Cesarean Section","status":"COMPLETED","sponsor":"Shahid Beheshti University of Medical Sciences","isPivotal":false,"enrollment":220,"indication":"Postpartum Hemorrhage","completionDate":"2013-09"},{"nctId":"NCT02861482","phase":"NA","title":"Early Usage of Bakri Postpartum Ballon is More Effective for the Management of Postpartum Hemorrhage","status":"COMPLETED","sponsor":"Dongyu Wang","isPivotal":false,"enrollment":472,"indication":"Postpartum Hemorrhage","completionDate":"2016-03"},{"nctId":"NCT01725243","phase":"NA","title":"Carbetocin at Cesarean Delivery for Labor Arrest: A Dose Finding Study","status":"COMPLETED","sponsor":"Samuel Lunenfeld Research Institute, Mount Sinai Hospital","isPivotal":false,"enrollment":40,"indication":"Postpartum Hemorrhage","completionDate":"2013-04"},{"nctId":"NCT01689298","phase":"NA","title":"Carbetocin vs. Oxytocin: In-vitro Myometrial Contractions With and Without Oxytocin Pre-treatment","status":"COMPLETED","sponsor":"Samuel Lunenfeld Research Institute, Mount Sinai Hospital","isPivotal":false,"enrollment":20,"indication":"Postpartum Hemorrhage","completionDate":"2012-08"},{"nctId":"NCT01579201","phase":"Phase 4","title":"ED90 Determination of Carbetocin for the Prevention of Postpartum Uterine Atony in Women Undergoing an Elective Cesarean Delivery","status":"UNKNOWN","sponsor":"Maisonneuve-Rosemont Hospital","isPivotal":false,"enrollment":40,"indication":"Postpartum Hemorrhage, Uterine Atony","completionDate":"2013-03"},{"nctId":"NCT03404544","phase":"Phase 4","title":"Evaluation of the Impact of Carbetocin Administration (Bolus Versus Infusion) on Heart Rate and Other Hemodynamic Parameters.","status":"COMPLETED","sponsor":"Ciusss de L'Est de l'Île de Montréal","isPivotal":false,"enrollment":70,"indication":"Cesarean Section Complications, Hemodynamic Instability","completionDate":"2021-01-15"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{"icon":"","route":"","frequency":"","formulation":""},"formularyStatus":[],"apiManufacturers":[],"developmentCodes":[],"ownershipHistory":[],"therapeuticAreas":["Other"],"biosimilarFilings":[],"firstApprovalDate":"","companionDiagnostics":[],"firstApprovalCountry":null,"genericManufacturerList":[],"modality":"Small molecule","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}